This multidisciplinary journal club will look at advancements in the field of pain medicine, new technology that is actively being developed or implemented, and review the literature related to any significant M&M cases in the department. The field is in a state of rapid change with the opioid crisis and faculty and participants need to remain at the forefront of the field.

 

This course is designed for physicians and advanced practitioners.

 

Brian Monroe, MD

Chelsea Britto, PA-C

Christina Miller

 

In support of improving patient care, Geisinger Commonwealth School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Geisinger Commonwealth School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

 

Geisinger Commonwealth School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

 

 

Geisinger Commonwealth School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its continuing education activities. Each person in a position to control the educational content of a CE activity must disclose the existence or non-existence of any financial relationship that they have with an ineligible company. There is no minimum financial threshold; individuals must disclose all financial information, regardless of the amount. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Any identified conflicts of interest will be resolved prior to the start of the activity. Subsequently, disclosure information is made available prior to the start of the activity.